# ABACAVIR SULFATE; LAMIVUDINE
> **ANDA090519** · Abbreviated New Drug Application (Generic) · Sponsor: MATRIX LABS LTD · Approved 2009-03-30
## Drug
- **FDA Application Number:** ANDA090519
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ABACAVIR SULFATE; LAMIVUDINE
- **Generic name:** Abacavir Sulfate
- **Active ingredients:** ABACAVIR SULFATE; LAMIVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MATRIX LABS LTD
- **First approval:** 2009-03-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090519)
---
*AI Analytics · CC0 1.0*